Daniel L Morgan Selected Research

Daniel L Morgan Research Topics

Disease

8	Inflammation (Inflammations) 09/2012 - 08/2002
7	Fibrosis (Cirrhosis) 01/2017 - 09/2007
6	Respiratory Hypersensitivity 01/2016 - 07/2004
4	Lung Injury 01/2019 - 01/2007
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2017 - 08/2002
4	Bronchiolitis 01/2017 - 05/2008
4	Bronchiolitis Obliterans 01/2017 - 04/2012
3	Neoplasms (Cancer) 01/2016 - 11/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2008 - 11/2005
2	Asthma (Bronchial Asthma) 09/2012 - 06/2010
2	Adenocarcinoma 01/2008 - 03/2007
2	Carcinogenesis 01/2008 - 03/2007
2	Pneumonia (Pneumonitis) 10/2006 - 08/2006
1	Hyperoxia 01/2019
1	Hyperplasia 10/2017
1	Immune System Diseases (Immune Disorders) 09/2012
1	Malignant Mesothelioma 10/2011
1	Infections 06/2010
1	Pleural Effusion (Pleural Effusions) 12/2009
1	Laryngitis 05/2008
1	Rhinitis 05/2008
1	Bronchitis 05/2008
1	Chronic Pancreatitis 03/2007

Drug/Important Bio-Agent (IBA)

8	Diacetyl (Biacetyl)IBA 01/2017 - 05/2008
5	OzoneIBA 01/2016 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 02/2015 - 03/2007
3	AllergensIBA 09/2012 - 10/2006
3	Proteins (Proteins, Gene)FDA Link 12/2010 - 10/2006
2	2,3-pentanedioneIBA 01/2017 - 04/2012
2	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 04/2009
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2011 - 09/2007
2	Prostaglandins EIBA 11/2011 - 08/2002
2	CollagenIBA 11/2011 - 09/2007
2	CytokinesIBA 06/2010 - 12/2009
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2007 - 08/2002
2	EicosanoidsIBA 09/2007 - 10/2006
1	sulforaphaneIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	4-ethyltoluene (p-ethyltoluene)IBA 10/2017
1	VX (EDIM)IBA 05/2017
1	Flavoring AgentsIBA 01/2017
1	Keratin-6 (Keratin 6A)IBA 01/2017
1	Keratins (Keratin)IBA 01/2017
1	MethacrylatesIBA 01/2016
1	dimethyl-4-toluidineIBA 01/2016
1	CarcinogensIBA 01/2016
1	dimethylpropiothetin (dimethylsulfoniopropionate)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2015
1	AmphiregulinIBA 10/2014
1	LigandsIBA 10/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2014
1	Transient Receptor Potential ChannelsIBA 09/2012
1	ProstaglandinsIBA 11/2011
1	Therapeutic UsesIBA 11/2011
1	Biological ProductsIBA 10/2011
1	EpitopesIBA 12/2010
1	Interleukin-4 (Interleukin 4)IBA 06/2010
1	OvalbuminIBA 06/2010
1	Immunoglobulin E (IgE)IBA 06/2010
1	Interleukin-13IBA 06/2010
1	AerosolsIBA 06/2010
1	Methacholine Chloride (Methacholine)FDA Link 06/2010
1	indium phosphideIBA 12/2009
1	carbonyl sulfideIBA 06/2009
1	Ceruloplasmin (Ferroxidase)IBA 01/2008
1	TrypsinIBA 01/2008
1	Peptides (Polypeptides)IBA 01/2008
1	Complement C3cIBA 01/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2007
1	Phosphotransferases (Kinase)IBA 04/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007
1	Mitogen-Activated Protein KinasesIBA 04/2007
1	NF-kappa B (NF-kB)IBA 04/2007
1	MicroRNAs (MicroRNA)IBA 03/2007
1	IronIBA 01/2007
1	MetalsIBA 01/2007
1	LeukotrienesIBA 10/2006
1	Cyclooxygenase 1IBA 10/2006
1	titanium dioxide (Titania)FDA Link 08/2006
1	Testosterone (Sustanon)FDA Link 07/2006
1	LipopolysaccharidesIBA 07/2006
1	Ribose (D-Ribose)IBA 11/2005
1	PentosesIBA 11/2005
1	Glucose (Dextrose)FDA LinkGeneric 11/2005
1	RNA (Ribonucleic Acid)IBA 11/2005
1	Hydroxyproline (4 Hydroxyproline)IBA 12/2004
1	Coal AshIBA 07/2004
1	EnzymesIBA 08/2002

Therapy/Procedure

2	Therapeutics 01/2008 - 11/2005
1	Oral Hygiene (Dental Hygiene) 06/2010
1	Castration 07/2006